Phage therapy – an alternative for antibiotics-resistance bacteria infections

Abstract

The emergence of pathogenic bacteria resistant to many currently available antimicrobial agents has become a critical problem in modern medicine, particularly due to the concomitant increase in immunosuppressed patients. Non-antibiotic therapies to treat bacterial infections are now under serious consideration and one possible option is the therapeutic use of specific phage particles. Bacteriophage therapy, discovered in the pre-antibiotic era, is currently gaining great interest due to its effectiveness and the ability to obtain phages from many different environments in which they live. This specificity makes phage therapy an attractive alternative in the treatment of infections, especially those caused by multidrug-resistant bacteria. The publication examines the problem of growing bacterial resistance to antibiotics and the need for novel methods of combating them. Phage therapy is presented as a promising alternative to traditional antibiotics, and its benefits are highlighted. The article also examines the challenges associated with phage therapy, such as accessibility, standardisation, regulatory concerns and the need for additional clinical trials. It highlights the significant potential of phage therapy to combat bacterial infections and its central role in shaping the future of medicine.